Acquisition by Kalich Ronald B Sr of 3853 shares of SurModics at 31.89 subject to Rule 16b-3
| SRDX Stock | USD 35.63 0.40 1.11% |
Slightly above 61% of SurModics' investor base is looking to short. The analysis of overall sentiment of trading SurModics stock suggests that many investors are alarmed at this time. SurModics' investing sentiment can be driven by a variety of factors including economic data, SurModics' earnings reports, geopolitical events, and overall market trends.
SurModics | Build AI portfolio with SurModics Stock |
Filed transaction by SurModics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
SurModics Fundamental Analysis
We analyze SurModics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SurModics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SurModics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
SurModics is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
SurModics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SurModics stock to make a market-neutral strategy. Peer analysis of SurModics could also be used in its relative valuation, which is a method of valuing SurModics by comparing valuation metrics with similar companies.
Peers
SurModics Related Equities
| OFIX | Orthofix Medical | 13.46 | ||||
| ANGO | AngioDynamics | 1.29 | ||||
| AORT | Artivion | 0.28 | ||||
| CNMD | CONMED | 0.04 | ||||
| NPCE | Neuropace | 0.67 | ||||
| ICUI | ICU Medical | 0.80 | ||||
| MMSI | Merit Medical | 1.04 | ||||
| CVRX | CVRx | 9.80 |
Additional Tools for SurModics Stock Analysis
When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.